InsiderTrades

Form 4 for ANIK Anika Therapeutics, Inc.

Accepted 2022-03-11 00:00:00 ET · period of report 2022-03-09 · accession 0001171843-22-001811 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-03-11 2022-03-09 ANIK Finnerty Thomas EVP, Human Resources F - Tax $26.22 -748 24.6K -3% -$19.6K
D 2022-03-11 2022-03-09 ANIK Finnerty Thomas EVP, Human Resources M - OptEx $0.00 +2,548 25.3K +11% $0
D 2022-03-11 2022-03-09 ANIK Finnerty Thomas EVP, Human Resources M - OptEx $0.00 -2,548 5,097 -33% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-03-09 F D 748 $26.22 24,598 D — — (F2) Reflects an aggregate of 748 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2022. (F3) Reflects the closing price of ANIK common stock on March 9, 2022, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
2 Common Common Stock 2022-03-09 M A 2,548 $0.00 25,346 D — — (F1) Reflects the first vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021.
3 Derivative Restricted Stock Unit 2022-03-09 M D 2,548 $0.00 5,097 D $0.00 · — to — 2,548 Common Stock (F4) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022.